Renata Grifantini
Has grant
General Director and Chief Scientific Officer
ItalyResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Renata Grifantini is the General Director and Chief Scientific Officer at CheckmAb S.r.l. in Italy. Her research primarily focuses on immunology and biomarker identification, with recent publications addressing topics such as antibody responses to tumor growth inhibitors and antiviral synthetic receptors for SARS-CoV-2. Additionally, her work includes serological profiling for flavivirus infections and the identification of autoantigens for diagnosing giant cell arteritis.
Recent Grants
Grant: Close
Call COVID19, IMPATTO DELL'INFEZIONE DI COVID-19 NELLE MALATTIE REUMATICHE CRONICHE TRATTATE CON FARMACI IMMUNOSUPPRESSORI (MAINSTREAM)
Open Date: 2020-01-01
Close Date: 2021-01-01
Grant: Close
Call COVID19, Caratterizzazione della risposta immunitaria protettiva in pazienti affetti da COVID-19 e realizzazione di un saggio immuno-diagnostico (Co-iMMUNITY)
Open Date: 2020-01-01
Close Date: 2021-01-01
Grant: Close
Second generation drugs for cancer immunotherapy (IMMUNHUB)
Open Date: 2019-01-01
Close Date: 2022-01-01
Grant: Close
Grant for Innovation in Oncology 2017 - Novel targets of tumor-infiltrating CD4+ regulatory T cells for immunotherapy
Open Date: 2018-01-01
Close Date: 2020-01-01
Grant: Close
Sviluppo di un saggio per la diagnosi precoce di artriti infiammatorie croniche sieronegative (ArtiDe)
Open Date: 2017-01-01
Close Date: 2021-01-01
Articles (12)
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (3)
Carlo Santambrogio
University of Milano-Bicocca
MARIACRISTINA CROSTI
-
Cristina Nativi
Full professor
University of Florence
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.